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a b s t r a c t
Background: Medical complications often worsen the prognosis after stroke. Our aim was to
investigate the association between particular noninfectious complications and hospital
mortality of acute stroke patients admitted to an urban Polish stroke center, and changes in
their occurrence from 1995 to 2015.
Methods: This is a retrospective analysis of 5174 consecutive patients admitted for acute
ischemic stroke or cerebral hemorrhage to a Polish urban stroke center between 1995 and
2015. The occurrence of complications was reported for years 1995–2000 (n = 883), 2001–2006
(n = 1567), 2006–2010 (n = 1539) and 2011–2015 (n = 1183). Odds ratios (OR) with 95% conﬁ-
dence interval (95% CI) for stroke unit death were calculated after adjustment for age,
congestive heart failure (CHF), pre-existing disability, stroke type and baseline neurological
deﬁcit in three different time periods.
Results: Over time there was a signiﬁcant decrease in the occurrence of myocardial infarc-
tion (MI) (2.2%, 1.4%, 1.0% and 0.3%, respectively), exacerbated CHF (4.6%, 5.1%, 2.6% and
2.0%) and deep vein thrombosis (DVT) (4.6%, 2.7%, 1.2% and 1.1%). Adjusted odds for stroke
unit death were increased by myocardial infarction (MI) (OR 17.5, 95% CI: 8.5–35.7), exacer-
bated CHF (OR 15.0, 95% CI: 9.8–23.0), pulmonary embolism (PE) (OR 11.5, 95% CI: 6.1–21.6),
gastrointestinal bleeding (OR 9.2, 95% CI: 4.4–18.9) and recurrent stroke (OR 5.4, 95% CI: 3.1–
9.3).
Conclusions: Over the last two decades Polish urban stroke units may have achieved a
signiﬁcant reduction of the occurrence of some noninfectious complications (i.e. MI, exac-
erbated CHF and DVT). However, the list of conditions associated with stroke unit mortality
includes not only MI and exacerbated CHF but also PE, gastrointestinal bleeding and
recurrent stroke.
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Despite signiﬁcant reduction in age-standardized incidence in
high-income countries and advances in treatment, the overall
burden of stroke continues to increase making it one of the
leading causes of death and disability worldwide [1]. This
burden results not only from the brain damage but also from a
variety of infectious and noninfectious complications [2,3].
Many of those complications are either fully preventable or
can be effectively managed if recognized early [2]. It has been
shown that increasing quality of acute stroke care decreases
the risk of most medical complications [4]. One may expect
that constant development and wide implementation of
modern stroke care over the years has led to their a signiﬁcant
decrease of their occurrence. The lack of deleterious weekend
effect on outcome after intravenous thrombolysis indirectly
proves decent quality of contemporary acute stroke care in
Poland but there are no studies that address complications [5].
Besides publications concerning early noninfectious compli-
cations of acute stroke in other countries are very heteroge-
neous in terms of deﬁnitions and reported occurrence [2–4,6–
17], and infrequenty report changes over longer periods of time
[7,14,15] or the effect on outcome [6,10–13,17].
The aim of our study was to investigate the association
between particular noninfectious complications and hospital
mortality in acute stroke and changes in their occurrence
among patients admitted to an urban Polish stroke center
between year 1995 and 2015.
2. Material and methods
2.1. Population
This is a retrospective registry-based analysis of consecutive
acute stroke patients admitted to a single stroke center
between July 1995 and December 2015. The center operates
as a part of department of neurology and provides health
services for a population of approximately 200,000–250,000
Caucasians living in a highly urbanized area (Southern
Warsaw, Poland). The center consists of intensive stroke unit
and early rehabilitation unit and has direct access to
interventional neuroradiology, neurosurgery and rehabilita-
tion wards.
2.2. Methods
The diagnosis of ischemic stroke or intracranial hemorrhage
was routinely based on clinical symptoms and noncontrast
brain computed tomography (CT) sometimes complemented
or substituted with brain magnetic resonance. The event was
considered acute if the onset of symptoms was within the last
7 days. Patients' data were prospectively collected in a detailed
stroke registry. The registry was created in 1991 as a
modiﬁcation of the National Institute of Neurological and
Communicative Disorders and Stroke Data Bank protocol, and
was upgraded in subsequent years [18–20]. Brieﬂy, collected
data include information about patient's demographics,
preexisting conditions and medications, diagnostic workup,the course of index stroke throughout hospital stay, stroke unit
adverse events, stroke unit treatment and outcome at
discharge to home, other ward or nursing home.
There were eight predeﬁned complications: deep vein
thrombosis (DVT), pulmonary embolism (PE), myocardial
infarction (MI), exacerbated congestive heart failure (CHF),
seizures, recurrent stroke, pressure sores and gastrointestinal
bleeding. The diagnosis was usually made by the attending
neurologist according to his best medical judgment. However,
in many cases it had to be conﬁrmed by additional examina-
tions or by a relevant consultant (internal medicine specialist,
cardiologist or surgeon). General criteria deﬁning each above-
mentioned condition are listed in Table 1. The information
about occurrence of a particular complication during whole
stroke unit stay was recorded in the registry as a nominal
variable. Events that began before stroke and was ongoing at
the time of admission to the stroke unit were not included.
Stroke severity was measured at admission and multiple
times during stroke unit stay with the use of Scandinavian
Stroke Scale (SSS) until year 2009 and National Institutes of
Health Stroke Scale (NIHSS) later on. For the purpose of this
analysis all SSS scores were converted to NIHSS using a
validated equation [21]. The level of prestroke disability of any
cause was measured with modiﬁed Rankin Scale (mRS).
Due to low absolute numbers of particular complications
per year we decided to evaluate longitudinal changes between
four consecutive time periods: (i) years 1995–2000, (ii) years
2001–2005, (iii) years 2006–2010 and (iv) years 2011–2015.
The paper follows Strengthening the Reporting of Observa-
tional Studies in Epidemiology guidelines [22].
2.3. Ethics
The registry was developed in concordance with the Declara-
tion of Helsinki and was approved by the local Ethics
Committee.
2.4. Statistical analysis
Categorical variables were presented as a number of valid
observations and proportions calculated with exclusion of
unknown values from the denominator. As the distribution of
continuous variables was mostly non-normal, they were
presented as a median with quartiles (1st quartile and 3rd
quartile; Q1, Q3).
Comparisons between particular time periods were done
using chi square test and Kruskal–Wallis test, as appropriate.
Only if the overall test for signiﬁcance was positive (P < 0.05),
pairwise comparisons were made between the ﬁrst time
period (i.e. years 1995–2000) and each consecutive time period
(e.g. years 1995–2000 vs. years 2011–2015). Additionally, similar
comparisons were made between each following time period
(i.e. years 2000–2005 vs. years 2006–2010 and years 2006–2010
vs. years 2011–2015). Such approach allows to minimize the
risk of type I error without losing power by applying the
Bonferroni correction.
Logistic regression was used to calculate odds ratios (ORs)
with 95% conﬁdence interval (95% CI) for stroke unit death.
Multivariable analyses were arbitrarily adjusted for age (as a
continuous variable), CHF, lack of prestroke dependency (mRS
Table 1 – Definitions of particular noninfectious complications recorded in the registry.
Complication Deﬁnition Conﬁrmation obtained from another specialist
Deep vein thrombosis Clinical signs of vein thrombosis in at least one lower
extremity conﬁrmed by ultrasound examination if
feasible.
Certiﬁed sonologist/radiologist or surgeon
Pulmonary embolism Clinical suspicion conﬁrmed by computed
tomography angiography.
Radiologist
Myocardial infarction Electrocardiography and/or laboratory ﬁndings
(cardiac enzymes, including troponins) consistent
with the diagnosis of any type of myocardial
infarction.
Internal medicine specialist or cardiologist
Exacerbation of congestive
heart failure
Clinical diagnosis. Internal medicine specialist or cardiologist
Seizure At least one seizure of any type that was either
witnessed directly by medical staff, unambiguously
described by a non-medical witness or recorded on
electroencephalography, irrespectively patient's
history of epilepsy.
Recurrent stroke New onset of focal neurological deﬁcit that cannot be
attributed to progression of the index brain infarct or
its hemorrhagic transformation that lasts more than
24 h and/or produces new lesion on neuroimaging.
Pressure sores New skin breaks or necrosis clearly resulting from
pressure or trivial trauma.
Gastrointestinal bleeding Clinical symptoms (i.e. hematemesis, coffee ground
emesis, melena or hematochezia not associated with
hemorrhoids).
Surgeon or internal medicine specialist
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ischemic stroke), baseline neurological deﬁcit (NIHSS as a
continuous variable).
P values of <0.05 were considered statistically signiﬁcant.
Calculations were carried out using STATISTICA 12.0 software
package (Stat Soft Inc., Tulsa, USA, 2013).
3. Results
3.1. General characteristics
The study included a total of 5174 acute stroke patients of
whom 883 were admitted in years 1995–2000, 1567 in years
2001–2005, 1539 in years 2006–2010 and 1183 in years 2011–
2015.
Throughout the studied period there was an overall trend
toward higher median age (from 72 years to 76 years). The
prevalence of hypertension, atrial ﬁbrillation and prestroke
dependency increased in years 2006–2010 and then remained
stable, whilst the prevalence of diabetes became signiﬁcantly
higher only in years 2011–2015 (Table 2). The proportion of
males, patients with ischemic stroke, CHF, coronary artery
disease, previous MI or previous stroke, current smokers and
excessive alcohol consumers did not change signiﬁcantly over
time (Table 2). Baseline neurological deﬁcit decreased from
median 11 NIHSS points in years 1995–2005 to 8 points in years
2006–10 and 7 points in years 2011–15. Median length of stroke
unit stay shortened from 17 days in years 1995–2000 to 10–11
days in years 2001–2015, whilst the median number of days
spent in intensively monitored bed ﬂuctuated between 3 to 1
(Table 2). There was also a signiﬁcant decrease in stroke unit
mortality from 19–21% in years 1995–2005 to 11–13% in years
2006–2015 (Table 2).3.2. Noninfectious complications
The occurrence of MI decreased from 1.4–2.2% in years 1995–
2005 to 1.0% in years 2006–2010 and then to 0.3% in years 2011–
2015 (Table 3). The proportion of patients experiencing
exacerbation of CHF was also reduced from 4.6–5.1% in years
1995–2005 to 2.0–2.6% in years 2006–2015 (Table 3). The
occurrence of DVT decreased from 4.6% in years 1995–2000
to 2.7% in years 2001–2005 and then to 1.1–1.2% in years 2006–
2015. The occurrence of PE (1.2–1.4%) or seizures (0.3–0.6%) did
not change signiﬁcantly throughout the studied period
(Table 3). Gastrointestinal bleeding was not observed in years
1995–2000, its occurrence increased to 1.7–1.9% in years 2001–
2010 and then dropped to 0.8% in years 2011–2015. An opposite
trend was observed in respect to pressure sores which were
reported for 3.2% of patients in years 1995–2000, then for 1.1–
1.6% in years 2001–2010, and again for 2.3% in years 2011–2015
(Table 3). The proportion of patients having recurrent strokes
ﬂuctuated between 0.9% and 2.3% with peak values in years
2001–2005 and 2011–2015 (Table 3).
3.3. Logistic regression
Unadjusted logistic regression suggested that each investigat-
ed complication, except for DVT, increases odds for stroke unit
death (Table 4). This was conﬁrmed after adjustment for age,
CHF, preexisting dependency, type of stroke and baseline
neurological deﬁcit for all complications with the exception of
seizures and pressure sores (Table 4). The strongest predictors
of hospital death were: MI (adjusted OR 17.5, 95% CI: 8.5–35.7),
exacerbated CHF (adjusted OR 15.0, 95% CI: 9.8–23.0) and PE
(adjusted OR 11.5, 95% CI: 6.1–21.6), followed by gastrointesti-
nal bleeding (adjusted OR 9.2, 95% CI: 4.4–18.9) and recurrent
stroke (adjusted OR 5.4, 95% CI: 3.1–9.3).
Table 2 – Patients' characteristics in particular periods.
Years
1995–2000
Years 2001–2005 Years 2006–2010 Years 2011–2015 Overall
N Value N Value N Value N Value P
General information
Male sex, no. (%) 883 396 (44.9) 1567 727 (46.4) 1539 700 (45.5) 1185 566 (47.8) 0.541
Age (years), median (Q1–Q3) 883 72 (64–81) 1567 73 (64–80) 1539 75 (65–82)* 1185 76 (66–83)*,y <0.001
mRS 0–2 before stroke, no. (%) 875 782 (88.4) 1561 1399 (89.6) 1535 1252 (81.6)*,y 1183 903 (76.3)*,y <0.001
Vascular risk factors
Hypertension, no. (%) 871 630 (72.3) 1556 1166 (74.9) 1528 1235 (80.8)*,y 1169 916 (78.4)* <0.001
Atrial ﬁbrillation, no. (%) 873 217 (24.9) 1556 404 (26.0) 1529 451 (29.5)*,y 1182 379 (32.1)* <0.001
Diabetes, no. (%) 883 184 (20.8) 1564 320 (20.5) 1538 348 (22.6) 1185 310 (26.2)*,y 0.003
Congestive heart failure, no. (%) 871 205 (23.5) 1541 350 (22.7) 1498 339 (22.6) 1156 264 (22.8) 0.962
Coronary artery disease, no. (%) 872 298 (34.2) 1543 510 (33.1) 1473 503 (34.2) 1162 343 (29.5) 0.053
Myocardial infarction in past, no. (%) 876 140 (16.0) 1556 210 (13.5) 1530 239 (15.6) 1175 179 (15.2) 0.268
Previous stroke, no. (%) 883 137 (15.5) 1560 240 (15.4) 1527 239 (15.7) 1182 198 (16.8) 0.781
Current tobacco smoking, no. (%) 859 215 (25.0) 1538 413 (16.9) 1495 398 (26.6) 1159 273 (23.6) 0.193
Excessive alcohol use (>300 g/week), no. (%) 829 53 (6.4) 1499 68 (4.5) 1493 67 (4.5) 1133 45 (4.0) 0.076
Current stroke
Stroke severity (NIHSS), median (Q1–Q3) 883 11 (5–19) 1565 11 (5–19) 1199 8 (3–16)*,y 1182 7 (3–15)* <0.001
Ischemic stroke, no. (%) 883 768 (87.0) 1567 1398 (89.2) 1539 1362 (88.5) 1185 1068 (90.1) 0.140
Day in stroke unit, median (Q1–Q3) 883 16 (10–25) 1567 11 (7–17)* 1532 10 (8–15)* 1184 10 (8–15)* <0.001
Days in monitored bed, median (Q1–Q3) 877 3 (1–5) 1495 2 (1–4)* 1509 1 (1–2)*,y 1178 2 (1–5)y <0.001
Death at discharge from the stroke unit, no. (%) 883 184 (20.8) 1567 299 (19.1) 1539 206 (13.4)*,y 1185 134 (11.3)* <0.001
mRS, modiﬁed Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; Q1, 1st quartile; Q3, 3rd quartile.
* Signiﬁcant difference compared to years 1995–2000.
y Signiﬁcant difference compared to the preceding time period.





Years 2006–2010 Years 2011–2015 Overall
N Value N Value N Value N Value P
Deep vein thrombosis, no. (%) 880 40 (4.6) 1558 42 (2.7)* 1536 19 (1.2)*,y 1175 13 (1.1)* <0.001
Pulmonary embolism, no. (%) 880 12 (1.4) 1558 21 (1.4) 1536 18 (1.2) 1175 16 (1.4) 0.963
Myocardial infarction, no. (%) 880 19 (2.2) 1558 22 (1.4) 1536 15 (1.0)* 1175 3 (0.3)*,y 0.001
Exacerbation of congestive heart failure, no. (%) 880 40 (4.6) 1558 79 (5.1) 1536 40 (2.6)*,y 1175 23 (2.0)* <0.001
Gastrointestinal bleeding, no. (%) 880 0 (0.0) 1558 26 (1.7)* 1536 29 (1.9)* 1175 9 (0.8)*,y <0.001
Seizure, no. (%) 880 3 (0.3) 1558 5 (0.3) 1536 6 (0.4) 1175 7 (0.6) 0.701
Recurrent stroke, no. (%) 880 8 (0.9) 1558 36 (2.3)* 1536 22 (1.5) 1175 25 (2.1)* 0.050
Pressure sores no. (%) 880 28 (3.2) 1558 25 (1.6)* 1536 17 (1.1)* 1175 27 (2.3)y 0.002
* Significant difference compared to years 1995–2000.
y Significant difference compared to the preceding time period.
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Reported data directly addresses the issue of noninfectious
medical complications experienced by acute stroke patients
admitted to a single stroke unit over a period of 20 years, which
allowed to collect enough cases to make calculation of
adjusted odds for hospital death relatively valid and robust.
The study was carried out in a homogenous cohort of patients
that may be considered representative for urban populations
of Poland and other Central and Eastern European countries
after economic transition.
Over the last two decades the occurrence of some
noninfectious complications in our stroke unit (i.e. MI, DVT,exacerbated CHF) signiﬁcantly decreased, whilst the occur-
rence of other complications remained relatively stable or
ﬂuctuated. There are probably multiple factors that contribut-
ed to this reduction, including improved infrastructure,
introduction of intravenous thrombolysis, improved prestroke
management of comorbidities, better general medical and
nursing care. The decrease in hospital mortality may have
resulted from better management of those complications
combined with lower stroke severity. However, one should
also note the 10% absolute reduction of the occurrence of
hospital infections (data not published).
According to our ﬁndings cardiac complications seem to be
the most important predictors of stroke unit death, both in
terms of strength of association and their occurrence. Previous
Table 4 – Odds ratios (ORs) for stroke unit death in particular time periods.
Unadjusted analysis Adjusted analysis
OR (95% CI) P OR (95% CI) P
Complications
Deep vein thrombosis 0.93 (0.55–1.59) 0.795 0.65 (0.35–1.20) 0.165
Pulmonary embolism 8.25 (5.03–13.51) <0.001 11.49 (6.13–21.56) <0.001
Myocardial infarction 13.82 (7.82–24.40) <0.001 17.47 (8.54–35.72) <0.001
Exacerbation of congestive heart failure 17.60 (12.53–24.72) <0.001 15.00 (9.76–23.03) <0.001
Seizure 3.30 (1.36–8.00) 0.008 2.58 (0.92–7.24) 0.072
Recurrent stroke 2.77 (1.79–4.30) <0.001 5.36 (3.08–9.34) <0.001
Gastrointestinal bleeding 10.67 (6.33–17.97) <0.001 9.17 (4.43–18.93) <0.001
Pressure sores 3.71 (2.46–5.61) <0.001 1.47 (0.90–2.40) 0.120
Covariables used for adjustment
Age (for each 5 years) 1.18 (1.14–1.22) <0.001 1.11 (1.07–1.16) <0.001
mRS 0–2 before stroke (vs. mRS 3–5) 0.50 (0.42–0.60) <0.001 1.12 (0.88–1.43) 0.351
Cerebral hemorrhage (vs. ischemic stroke) 5.11 (4.24–6.16) <0.001 2.88 (2.24–3.71) <0.001
Baseline NIHSS score (for each additional 4 points) 2.27 (2.15–2.40) <0.001 2.15 (2.03–2.28) <0.001
Congestive heart failure 2.21 (1.88–2.61) <0.001 1.50 (1.21–1.86) <0.001
mRS, modiﬁed Rankin Scale; NIHSS, National Institutes of Health Stroke Scale.
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patients [2,7,9,14,15,17] and increases risk of hospital death
and non-cardiac complications [17]. The occurrence of MI in
our cohort clearly decreased over time, which follows the
pattern observed in Norway between year 2003 and 2013 [14]
but not in the United States of America (years 1998 to 2007 for
ischemic stroke and years 2004 to 2014 for cerebral hemor-
rhage hospital admissions) [7,15]. Exacerbated CHF was
reported in 0.6% to 11% of acute stroke patients, which
probably reﬂects difﬁculties in deﬁning this particular condi-
tion [2,10]. We found a signiﬁcant decrease of its occurrence
between years 2001–2005 and years 2006–2010. One may
speculate that continuous patient monitoring allows to detect
early signs of cardiac ischemia or tachyarrhythmia that can be
effectively managed before leading to more serious complica-
tions [14]. If we consider infrastructural and educational gains
from the contemporary National Cardiovascular Disease
Prevention and Treatment Program in Poland, this may be
the major reason of this phenomenon [23].
Our data conﬁrm that PE is a strong and independent
predictor of hospital death [6]. The occurrence of PE was
slightly higher than in other reports (0.2–1.0%) [2,6–10,15] and it
remained stable throughout the study period, conversely to
slight but signiﬁcant increase observed in the United States of
America [7]. In the same time, the occurrence of DVT in our
cohort gradually decreased from 4.6% to 1.1%, which again is
not in line with data from the United States [7,15]. This
discrepancy may indirectly reﬂect the change that in prophy-
lactic approach, as well as growing prevalence and better
detection in the United States [7,24]. Overall, our results ﬁt in
the range of occurrence reported by other groups (0.2–4.0%),
and do not support uncertain association between DVT and
the risk of death [2–4,6–11,15].
In the literature the rates of early recurrence range from
0.5% to 18%, depending on the setting and the duration of
follow-up after the presenting stroke [8–10,12,13]. It has
already been shown that recurrent stroke worsens 90-day
outcome [12]. However, our study is the ﬁrst to provide direct
evidence that the recurrence which happens during the initialhospital stay independently decreases chances of being
discharged alive.
Previously reported rates of gastrointestinal bleeding were
higher (2.0–5.0%) than in our study [2,6,9,10]. However, our data
fully support its strong association with hospital death
described by Wang and colleagues [6].
The occurrence of pressure sores ranged in our cohort from
1.1% to 3.2% without a clear trend over time, which is in line with
other studies (0.3 up to 21% after inclusion of subacute patients)
[2–4,6,8–11]. It is not clear whether pressure sores independently
predict poor outcome and our results do not support their
independent association with hospital mortality [6,10,11].
Seizures were observed in 0.3–0.6% of our patients, which
complies with the lower limit of range reported in other studies
(0.5–3.8%, up to 23% if the subacute patients are included)
[9,10,13,16]. The evidence about negative effect of post-stroke
seizures on mortality is conﬂicting [10,13]. Our data suggest that
such association may exist. However, it needs to be noted that
statistical signiﬁcance was lost after adjustment for confoun-
ders and the absolute number of cases was low (n = 21).
4.1. Study limitations
The study has several limitations that need to be noted. Data
were collected in a prospective manner using a predeﬁned
questionnaire but the analysis is retrospective. The informa-
tion about each patient was entered to the registry by the
attending physician. Therefore we may not ensure that all
reported events fully complied with provided deﬁnitions.
However, to improve internal validity each paper question-
naire was checked and approved by the supervising stroke
neurologist before digitization. Because of missing data in
particular variables some cases had to be excluded from the
adjusted analysis but considering large sample size, it
was unlikely to bias the results. The registry does not
include information about patient's ethnicity and place of
residence. However, it may be reliably assumed that almost all
participants were Caucasians living in a highly urbanized area.
It should also be noted that each event was recorded only as a
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about its time of onset, duration, direct outcome and number
of events if the complication occurred more than once.
Ultrasound examination of lower extremities was not per-
formed routinely, including patients who developed PE
without clinical signs of DVT. It might have introduced bias
toward lower occurrence of DVT but on the other hand clearly
not all cases of ultrasound detected DVTs are clinically
manifested or associated with the current stroke [25].
5. Conclusion
Our ﬁndings suggest that over the last two decades Polish
urban stroke units achieved a signiﬁcant reduction of the
occurrence some noninfectious complications (i.e. MI, exacer-
bated CHF and DVT). It may have contributed to the decrease of
stroke unit mortality. However, the list of complications that
predict hospital mortality includes also PE, recurrent stroke or
gastrointestinal bleeding. Therefore further efforts are needed
to improve their prevention and management.
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